Does mild renal insufficiency increase risk for adverse effects with this glucagon-like peptide 1 analogue?
How should growth hormone be dosed in children approaching puberty?
Dr. Richard Kloos explains when and why people should stock or take potassium iodide (KI) to combat potential radiation exposure.
Can this weight loss agent help improve the cardiovascular risk profile of patients with PCOS?
New research compares T cell populations in patients with Hashimoto's thyroiditis to patients with other T cell-mediated autoimmune diseases.
The results from a new meta-analysis sheds light on the metabolic effects of testosterone therapy in men with type 2 diabetes or the metabolic syndrome.
Learn about the complex inter-relationships between obesity, T2DM, sleep disorders, and hypogonadism in men.
EASD President Andrew Boulton offers a sneak peek at the program of the upcoming European meeting in Stockholm.
What are strong drivers of response to mifepristone therapy in patients with Cushing disease?
Want to solve a family argument? This research will answer the question of who is taller... You or your older sibling.
What should you be concerned about when managing primary hyperparathyroidism in elderly patients?
What health risks are associated with high triglyceride levels?
How common is 'healthy' obesity among different populations?
Can these anti-obesity agents effectively prevent prediabetes from developing into type 2 diabetes?
The AACE and ACE issue a joint position statement regarding the connection between testosterone replacement therapy and cardiovascular risk in hypogonadal men.
People who exercise regularly have lower plasma triglyceride concentrations, but what are the mechanisms responsible for this phenomenon?
In spite of numerous setbacks, the quest to find a safe and effective weight-loss drug continues.
Urogenital dysfunction, walking impairment, and pain are common complications of diabetic neuropathy. Solomon Tesfaye comments on the latest EASD studies in this field.